Javier Molina‐Cerrillo

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Toni K. Choueiri, Laurence Albigès, Philippe Barthélémy et al. · The Lancet · 2024 · 54 citations · Full text

Urology, Genitourinary Cancer, Medicine +8

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 52 citations · Full text

Differential Effectiveness, Urology, Genitourinary Cancer +7

The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)

Enrique Grande, Àlex Teulé, Teresa Alonso‐Gordoa et al. · The Oncologist · 2020 · 40 citations · Full text

Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors

Matteo Santoni, Francesco Massari, Sergio Bracarda et al. · European Urology Focus · 2022 · 36 citations · Full text

Urology, Genitourinary Cancer, Medicine +7

Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs

Elisa Conde, Alejandro Pascual, Juan Daniel Prieto Cuadra et al. · Cancers · 2019 · 34 citations · Full text